Increased insulin resistance, reduced insulin secretion from the pancreas, and glucose intolerance were observed in patients with pancreatic cancer [56] as well as in animal models, and are associated with higher cancer mortality in a longitudinal study [57]. The gene discussed is INS; the disease is Insulin resistance.